HealthDay News — Paternal exposure to valproate during sperm development is not associated with neurodevelopmental disorders (NDDs) in offspring, according to a study published online August 19 in ...
Phase 3 RASolute 302 data show daraxonrasib significantly extended overall and progression free survival compared with ...
Interim Phase 1b/2a trial data support the MKK4 inhibitor's potential to protect hepatocytes and accelerate liver regeneration following surgical resection.
The FDA has approved Tivicay PD dispersible tablets for combination HIV-1 treatment in full-term neonates weighing at least 2kg.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results